Insider Stock Trading History of Baker Bros. Advisors (gp) Llc


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Baker Bros. Advisors (gp) Llc since year 2005. The trader's CIK number is 1580575. At the time of this reporting, Baker Bros. Advisors (gp) Llc is the 10% Owner of Bellicum Pharmaceuticals, Inc . (stock ticker symbol BLCM). See this page for all insider trading activities at Bellicum Pharmaceuticals, Inc .

Note that in the past Baker Bros. Advisors (GP) LLC also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Baker Bros. Advisors (gp) Llc since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-03-24 BLCM Bellicum Pharmaceuticals, Inc Buy 166,666 12.00 1,999,992
2016-11-17 NVTA Invitae Corp Buy 733,333 6.00 4,399,998
2016-06-07 MRTX Mirati Therapeutics, Inc. Sale 296,200 9.44 2,795,535
2016-06-08 MRTX Mirati Therapeutics, Inc. Sale 158,100 9.21 1,456,417
2016-06-09 MRTX Mirati Therapeutics, Inc. Sale 545,058 9.48 5,166,604
2016-05-11 NTLA Intellia Therapeutics, Inc. Buy 200,000 18.00 3,600,000
2016-04-01 ACAD Acadia Pharmaceuticals Inc Buy 302,900 28.18 8,536,933
2016-03-30 ACAD Acadia Pharmaceuticals Inc Buy 462,546 26.08 12,064,124
2016-03-31 ACAD Acadia Pharmaceuticals Inc Buy 683,644 26.70 18,255,345
2016-03-15 INCY Incyte Corp Buy 400,000 66.08 26,431,599
2016-03-17 INCY Incyte Corp Buy 400,000 61.36 24,543,600
2016-03-17 INCY Incyte Corp Option Ex 60,000 3.86 231,600
2015-09-16 INCY Incyte Corp Option Ex 4,623,926 .00 0
2015-09-16 MRTX Mirati Therapeutics, Inc. Buy 150,000 45.00 6,750,000
2015-05-11 INCY Incyte Corp Option Ex 60,000 7.68 460,800
2015-02-13 IDRA Hybridon Inc Buy 5,333,333 3.75 19,999,998
2015-01-07 GEVA Trimeris Inc Buy 1,000,000 94.19 94,190,000
2014-05-21 INCY Incyte Corp Option Ex 30,000 7.02 210,600
2014-03-05 ACAD Acadia Pharmaceuticals Inc Buy 526,316 28.50 15,000,006

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baker Bros. Advisors (gp) Llc (10% Owner of Bellicum Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.